Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

Best Medical Oncologist in Birmingham, UK

0 results found for 'Medical Oncologist ' in Birmingham, UK

Sort by:
We didn't find any results for your search within 15 miles of Birmingham, UK
Here are closest specialists matching your search
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
Genesis Care Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
Expert in: Bladder Cancer, Bowel Cancer, Colon Cancer, Colorectal Cancer + 5 more
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
Genesis Care Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
Recommended by 1 specialist
29 years of experience
Expert in: Biological Therapy, Bladder Cancer, Chemotherapy, Hormone Therapy + 4 more

Professor. Andrew Protheroe is an Associate Professor of Uro-Oncology within the University of Oxford Department of Oncology at the Oxford Cancer and Haematology Centre. He is a highly experienced Consultant Medical Oncologist specialising in managing urological cancer (prostate, kidney, bladder and testicular cancer) at Oxford since 2001. He qualified from St Thomas’s Hospital in London and after general medical training in London, trained in Oncology at St James’s University Hospital in Leeds. His PhD was in tumour immunology and the research was based at Leeds and the National Cancer Institute in Amsterdam as an Honorary ICRF Clinical Research fellow funded by a Northern and Yorkshire research award.  

Professor. Protheroe specialises in managing and overseeing patients with urological cancer providing specialised expert care to patients and their families covering all aspects of chemotherapy, hormonal therapy, immunotherapy, radium 223, growth inhibitors and novel therapies; giving plentiful options to give patients as many options as possible.

In addition to his other work, he is also one of the founding trustees for the urological cancer charity UCARE which supports research and awareness. He was also instrumental in setting up the kidney cancer support group (FROG), and helped to develop the prostate and bladder cancer support groups and set up initiatives to support men with testicular cancer.

It is clear from Professor Protheroe's work in both clinical practice, research and charity work that he is fully invested in the clinical care of his patients but also supporting their emotional wellbeing, giving them the best overall experience in their cancer journey.


Diseases, Medical Tests and Treatments
  • Immunotherapy
  • Personalised medicine for urological cancers
  • Gastroesophageal
  • Head and neck oncology
  • Chemotherapy
  • Haemato-oncology
  • Breast ultrasound
  • Prostate Cancer
  • Bladder Cancer
  • Kidney Cancer
  • Testicular Cancer
Read more
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
Genesis Care Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
14 years of experience
Expert in: Breast Cancer, Breast Pain Management, Chemotherapy, Clinical Trials + 2 more

Dr Maria Karina is a Medical Oncologist Consultant in the UK since 2011. Having completed her primary Medical Education in Thessaloniki, Greece she also trained in Internal Medicine, until 1998 before coming over to the UK to continue her medical career.

Her training in Medical Oncology started in 2000 with a fellowship at the Aristotle University of Thessaloniki and her PhD in Gastric Cancer Immunohistochemistry Biomarkers, furthering her medical knowledge and satifying her interest in medical research. She continued with a fellowship in Clinical Trials at the EORTC Headquarters in Brussels.

Dr. Karina continued her Medical Oncology training in the UK in 2006 at the Christie hospital (Manchester UK) and completed in 2011 (Birmingham, West Midlands UK) since which she has been working as a consultant oncologist.

Her areas of expertise include breast and lung cancer. She continues to be actively involved in research and she is the lead for the Oncology research team in the Milton Keynes hospital in addition to her practice.


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Breast cancer management
  • Lung cancer management
  • Breast Cancer
  • Lung Cancer
Read more
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 56.25 miles
Genesis Care Milton Keynes - 56.25 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
21 years of experience
Expert in: Anal Cancer, Bowel Cancer, Breast Cancer, Breast Pain Management + 16 more

Dr Sarah Smith is the Clinical Director for Oncology and Palliative Care at Bedford Hospital and also holds the position as Governance Lead at Addenbrooke's Hospital, in addition to her private practice at GenesisCare Milton Keynes. She specialises in rectal, ovarian and endometrial cancer treatment in Bedford Hospital and has opened multiple nationally-recognised trials for local patient participation; striving to better patient treatment and care.

Dr Smith undertook her initial medical training at Imperial College London, graduating in 1998. Dr Smith also obtained BSc Medical Science at St. Bartholomew's and the Royal London School of Medicine in 1997.

After completing her general medical training, during which time she obtained her MRCP, she went onto the specialist registrar clinical oncology London training programme for five years, working at various London hospitals during this time, including University College Hospital, Mount Vernon Hospital and the Royal Marsden Hospital, and also obtained her FRCR. Dr Smith joined Bedford Hospital NHS Trust in 2008 as a Consultant Clinical Oncologist.


Diseases, Medical Tests and Treatments

  • Breast Pain Management
  • Chemotherapy
  • Clinical Trials
  • Radiotherapy
  • Stereotactic Ablative Radiotherapy (SABR)
  • Stereotactic Radiosurgery (SRS)
  • Video Consultation
  • Image Guided Radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Radiotherapy
  • RapidArc Or Volume Modulated Arc Therapy (VMAT)
  • Deep Inspiration Breath Hold
  • Flexible Cystoscopy
  • Palliative Radiotherapy
  • Surface Guided Radiotherapy (SGRT)
  • Anal Cancer
  • Bowel Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Endometrial Cancer
  • Gynaecological Cancers
  • Ovarian Cancer
  • Rectal Cancer
Read more
300 Park Ave, Bristol, United Kingdom, BS32 4SY - 71.33 miles
Genesis Care Bristol - 71.33 miles
300 Park Ave, Bristol, United Kingdom, BS32 4SY
28 years of experience
Expert in: Breast Cancer, Breast Pain Management, Chemotherapy, Clinical Trials + 4 more

Dr. Jeremy Braybrooke is a Consultant Medical Oncologist based at University Hospitals Bristol NHS Foundation Trust with his private practive also in Bristol. He trained in Medical Oncology at the Cancer Research UK Medical Oncology unit in Oxford. During this time I completed a PhD and developed an interest in drug development and clinical trials.

Dr. Braybrooke has worked in Bristol since 2003 and developed a large research based clinical practice specialising in breast, testicular and germ cell cancers. He is the lead clinician for oncology at Bristol Haematology and Oncology Centre. He is also enthusiastic about improving patients’ experience of chemotherapy treatments and have helped lead the development of home and community chemotherapy services in Bristol.

Dr. Braybrooke sits on a NICE Technology Appraisal Committee evaluating new medicines. He is actively involved in clinical research and has recently been appointed as a part-time Senior Clinical Research Fellow with the Early Breast Cancer Trialists Collaborative group based at Oxford University. In addition to this, he has co-authored over 30 peer-reviewed publications; endeavouring to provide the highest quality care for all of his patients moving forward.


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Clinical Trials
  • Breast Cancer
  • Testicular Cancer
  • Germ cell cancers
Read more
300 Park Ave, Bristol, United Kingdom, BS32 4SY - 71.33 miles
Genesis Care Bristol - 71.33 miles
300 Park Ave, Bristol, United Kingdom, BS32 4SY
22 years of experience
Expert in: Bladder Cancer, Brachytherapy, Breast Cancer, Cancer Prevention and Screening + 17 more

Professor Bahl is an internationally renowned expert on all aspects of prostate cancer treatment and can discuss the intricacies of the new modalities of treatment including IMRT, proton therapy, single modality HDR brachytherapy, enabling patients to come to an informed decision, knowing they are in the most expert hands. Professor Bahl has been an expert adviser to NICE for the technology appraisal on new drugs and an external service reviewer at oncology departments elsewhere in the country.  

Prior to Professor Bahl's current roles, he became member of the Royal College of Physicians (UK) and trained in clinical oncology, achieving the fellowship of the Royal College of Radiologists qualification, he has also been awarded the fellowship of the Royal College of Physicians and is a current member of the National Cancer Research Institute Clinical Studies Groups for bladder cancer and chair the penile cancer subgroup. Professor Bahl has been college tutor of the Royal College of Radiologists for 10 years and has supervised several MD theses in breast and prostate cancer research. He has previously been in the NCRI renal and prostate clinical studies group. He is an Executive Committee member of the British Uro-oncology Group. 

In addition to his extensive qualifications, Professor Bahl is also actively involved in research into breast, prostate, bladder and penile cancers and has more than 100 publications in these research areas and has several presentations at national and international meetings. In 2012, he was awarded the Cochrane Shanks Jalil Professorship by the Royal College of Radiologists, London and is a Visiting Professor to two international centres and at the University of West of England. He currently holds research grants in excess of £2million and is Chief Investigator for several multicentre trials including ATLAS, CONCEPT and ACE which are focusing on new modalities of treatment in breast and prostate cancer and is also leading the robotic brachytherapy project. Professor Bahl is at the forefront of medical research and there are few doctors better qualified than him.

Professor Bahl is currently Consultant Clinical Oncologist at Bristol Cancer Institute, University Hospitals Bristol with a special interest in breast and urological cancers as well Research lead for uro-oncology at Bristol Haematology and Oncology Centre. Led and developed the prostate brachytherapy service at Bristol. He is the head of oncology at Spire Bristol and Clinical Director at GenesisCare Bristol; the centres are lucky to have such an internationally renowned professional as their director.


Diseases, Medical Tests and Treatments
  • Radiotherapy
  • Chemotherapy
  • IMRT
  • Proton therapy
  • Single modality
  • HDR brachytherapy
  • Bladder cancer,
  • Breast cancer,
  • Genito-urinary cancer,
  • Kidney cancer
  • Prostate cancer
Read more
Rickmansworth Road, Northwood, London, United Kingdom, HA6 2JW - 86.50 miles
BMI Bishops Wood Hospital - 86.50 miles
Rickmansworth Road, Northwood, London, United Kingdom, HA6 2JW
Recommended by 1 specialist
27 years of experience
Expert in: Brain Cancer, Brain Tumours, Brain Metastasis, Clinical Trials + 3 more

Dr Mulholland is a medical Oncologist who exclusively treats brain cancer at University College Hospital, the National Hospital for Neurology and Neurosurgery (part of UCLH) and Mount Vernon Cancer Centre.He is also an honorary senior lecturer at UCL and a training programme director. 

His doctoral research was in genomic profiling in brain cancer at Cancer Research UK - this has led to his focus on developing biomarkers and targets for therapy in brain cancer, including the clinical trial portfolio of novel agents in brain cancer which he now runs at UCLH and nationally. 

He is a clinical lead in a European Consortium called Datrix, a multidisciplinary European collaboration to advance next-generation targeted hyperthermic cancer treatment for glioblastoma.

 

 

 


Diseases, Medical Tests and Treatments

  • Cancer prevention and screening 
  • Chemotherapy 
  • Brain cancer 
  • Neuro-endocrine tumours 
  • Central nervous system cancer 
  • Novel agents 
Read more
Heathbourne Road, Watford,, Bushey,Hertfordshire, United Kingdom, WD23 1RD - 88.47 miles
Spire Bushey Hospital - 88.47 miles
Heathbourne Road, Watford,, Bushey,Hertfordshire, United Kingdom, WD23 1RD
25 years of experience
Expert in: Adenocarcinoma, Anal Cancer, Bilary Cancer, Bile Duct Cancer (Cholangiocarcinoma) + 41 more

Dr Gaya qualified at St George’s (University of London) where he was awarded a distinction and several academic prizes. He trained in Clinical Oncology at Imperial College and St Bartholomew’s Hospital and subsequently undertook a Cancer Research UK MD Fellowship at University College London. He was a consultant clinical oncologist at Guy's and St Thomas' Hospitals for 15 years.

Dr Gaya treats all gastrointestinal tumours (e.g. oesophagus, stomach, liver, pancreas, colon, rectum, anus) using chemotherapy, radiotherapy, immunotherapy, biological therapies, and data from tumour genome analysis. Dr Gaya’s main interests are in the areas of functional cancer imaging (Kings College, London), and combining immunotherapy with radiation treatment.

He is heavily involved with the implementation and usage of the latest radiotherapy techniques such as MRI guided radiotherapy, proton therapy and stereotactic body radiosurgery (gamma knife, cyberknife). He has published and peer-reviewed widely for international journals.

Offering both drug-based and radiation-based therapies and close liaison with surgical and interventional radiology, he is a leading authority on the unique combination of multiple treatment modalities and personalised tumour molecular profiling into a treatment package for each patient.

Dr Andrew Gaya is a renowned and respected Consultant Oncologist with HCA Healthcare. He helps those with care and compassion at a time when they need it most. His vast experience enables him to provide a first-class service to those suffering from cancer.

In his spare time, he enjoys staying active by diving, tennis and football.


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • External beam radiotherapy (including IMRT and IGRT)
  • Biological and targeted therapies
  • Immunotherapies
  • Stereotactic radiotherapy (SBRT, SABR, Cyberknife)
  • MRI Guided Stereotactic Radiotherapy (MR Linac)
  • Proton therapy
  • SIRT (radioembolisation)
  • Next generation sequencing and molecular analysis of tumours
  • Chemotherapy sensitivity testing
  • Gastrointestinal Cancer
  • Bowel Cancer
  • Rectal Cancer
  • Anal Cancer
  • Liver Cancer
  • Stomach Cancer
  • Pancreatic Cancer
  • Skin Cancer
  • Cancer of Unknown Primary
Read more
St Johns Wood, London, United Kingdom, NW8 7JA - 98.61 miles
The Wellington Hospital - 98.61 miles
St Johns Wood, London, United Kingdom, NW8 7JA
15 years of experience
Expert in: Chemotherapy, Colorectal Cancer, Bowel Cancer, Adenocarcinoma + 24 more

Dr Khan is a research-active consultant who trained in medical oncology at the Northern Ireland Cancer Centre and Royal Marsden NHS Foundation Trust London. After working as a Locum Consultant at Royal Marsden for 21 months, he took substantive consultant position in Gastrointestinal Oncology at UCLH. He also attends North Middlesex University Hospital (NMUH), where he is the Clinical Lead of Carcinoma of Unknown Primary (CUP) and Clinical Research in Oncology. Dr Khan was awarded the Robert McAlpine fellowship and studied mechanisms of response and resistance to targeted therapies in advanced colorectal cancer. He gained an MD(Res) degree under the supervision of Professor David Cunningham at the Institute of Cancer Research and the Royal Marsden Hospital. He was involved in setup and conduct of large multi-centre academic and translational studies from the time that he spent in full-time research, which included working as a trial physician for phase II/III studies in early and advanced gastrointestinal cancers.

Dr Khan's main research interests involve stratification of therapies in patients with gastrointestinal malignancies, by setting up studies of clinical and translational relevance.

He presented and lectured in international conferences and public forums respectively. He published several high impact papers in peer-reviewed journals including Science, Cancer Discovery, Cancer Cell, Gut, Gastroenterologist, Clinical Cancer Research, Oncogene, Oncologist, BMC Medicine, BMC Cancer, British Medical Journal (BMJ) and British Journal of Cancer. He also served as an expert member of the National Research and Ethics Committee.

Dr Khan also played an active role in improving the educational experience of the junior doctors nationally. He writes questions for MRCP(UK) and Medical Oncology exams and remains part of the national medical oncology recruitment panel. Dr Khan's publications can be accessed via the link below:

https://scholar.google.co.uk/citations?user=yfq8mGcAAAAJ&hl=en&oi=ao

Dr Khan's seceratary Alanna Sarwar can be approached at +44(0)207 317 2659 and she can be emailed directly at asarwar@theloc.com


Diseases, Medical Tests and Treatments
  • Gastrointestinal Cancer Research
  • Colorectal cancers 
  • Colon cancers
  • Rectal cancers
  • Anal cancers 
  • Upper GI Cancers
  • Gastric cancers
  • oesophageal cancers
  • Hepato-biliary malignancies
  • Cholangiocarcinoma
  • Gall bladder cancers
  • Pancreatic cancers
  • Carcinoma of Unknown Primary
  • Gastrointestinal Cancer Research
  • Colorectal cancer
  • Newly diagnosed cancers
  • Molecular Genetics
  • Liquid Biopsies
Read more
15-17 Lodge Road, London, United Kingdom, NW8 7JA - 98.62 miles
Platinum Medical Centre - 98.62 miles
15-17 Lodge Road, London, United Kingdom, NW8 7JA
21 years of experience
Expert in: Biological Therapy, Chemotherapy, Clinical Trials, Immunotherapy + 5 more

Dr Thomas Newsom-Davis a Consultant Medical Oncologist at Chelsea and Westminster Hospital. He specialises in thoracic malignancies, especially lung cancer and mesothelioma. In 2015, he was awarded the Macmillan Innovation Excellence Award.

Training

Dr Newsom-Davis completed his training at University College and Middlesex School of Medicine, London, in 1998, including First Class honours for his BSc. He went on specialise in medical oncology at Charing Cross and Hammersmith Hospitals and completed a PhD in tumour immunology. He was appointed to Chelsea & Westminster Hospital in 2010.

Current Roles

Dr Newsom-Davis leads the lung cancer service for Chelsea & Westminster Hospital, and is Vice Chair of the British Thoracic Oncology Group (BTOG) Steering Committee, an organistion which supports and educates thoracic oncology profressionals across the United Kingdom. Dr Newsom-Davis is Chair of the Harley Street Clinic lung cancer multidisciplinary team (MDT), and Chair of the HCA Healthcare UK Thoracic Oncology Board.

Research

Dr Newsom-Davis has an active clinical trial portfolio, and has presented his work at National and International meetings. He has been an invited lecturer for organisations including the Royal College of Physicians, European Society of Medical Oncology, International Association for the Study of Lung Cancer, British Medical Association and the Association of Cancer Physicians.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Diseases, Medical Tests and Treatments

  • Immunotherapy, Targeted Therapy, Chemotherapy
  • Lung Cancer
  • Mesothelioma
Read more